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CONNECTIVE TISSUE ACTIVATION 
XXV. Regulation of Proteoglycan Synthesis in Human Synovial Cells 
C. W. CASTOR, D. J. ROBERTS, P. A. HOSSLER, and M. C. BIGNALL 
In this study, virtually all sulfated glycosamino- 
glycan (GAG) synthesized and secreted by human syno- 
vial cells, both normal and rheumatoid, was detected in 
the form of proteoglycans of monomeric size. Enzyme 
hydrolysis studies that were performed demonstrated 
dermatan sulfate to be the dominant GAG in the 
proteoglycan, with lesser amounts of chondroitin 416 
sulfate. Exposure to Pxyloside, used as a false “core 
protein,” resulted in marked enhancement of GAG 
chain formation, suggesting that the synthesis of the 
sulfated carbohydrate chain itself was not rate limiting. 
Proteoglycan synthesis and secretion were stimulated by 
several types of connective tissue activating peptides 
(CTAP); CTAP-111 stimulation of incremental core pro- 
tein and glycosaminoglycan was shown to be of a similar 
magnitude. Since chain synthesis was not rate limiting, 
it is suggested that stimulated proteoglycan formation 
caused by the CTAP peptides may be primarily modu- 
lated through increased formation of core protein. 
We have shown that human connective tissue 
cells may be activated by low molecular weight pro- 
teins found in leukocytes, platelets, and other nucleat- 
ed cells (1-6). Defined mediators, termed connective 
tissue activating peptides (CTAP), are found in lym- 
phoid tissue (CTAP-I, CTAP-Ib), tumor cells (CTAP- 
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II), platelets (CTAP-111, CTAP-P2), and polymorpho- 
nuclear cells (CTAP-PMN). Placing these peptides in 
contact with human fibroblasts results in increased 
glycolysis, increased formation of glycosaminoglycans 
(GAG), and sometimes increased DNA synthesis. 
Earlier studies showed that CTAP-stimulated hyal- 
uronic acid formation in human synovial cultures 
resulted, in large measure, from increased hyaluronic 
acid synthetase activity in forming incremental hyal- 
uronate chains (7). 
Previous studies (8,9) have documented that 
human synovial cell cultures synthesize sulfated gly- 
cosaminoglycan (SO,-GAG); no data have clearly de- 
fined this material as  proteoglycan. This report focus- 
es on increased formation of SO4-GAG in activated 
synovial cultures, and presents evidence indicating 
that S04-GAG synthesized in vitro is a proteoglycan 
(PG) monomer. The increased formation of proteogly- 
can under circumstances of activation may be modu- 
lated by increased formation of core protein. 
MATERIALS AND METHODS 
Culture and isotopic methods. Human synovial fibro- 
blasts were isolated by an explant method and subsequently 
subcultured in plastic or glass flasks as previously reported 
(10). Cultures derived in this way were propagated using 
medium 1066 (go%), 10% fetal calf serum, and 10% human 
serum. Complete medium changes were carried out 3 times a 
week and trypsin dispersal was performed as required for 
propagation or study. Freezing procedures were as previous- 
ly reported (10). DNA synthesis was measured by determin- 
ing the incorporation of 3H-methylthymidine into cells in 
microtiter well cultures, using lo4 cells per culture (3). 
Formation of ‘‘C-glycosaminoglycan and 3SS-glycosamino- 
glycan was measured in microtiter well cultures using 2 x 
lo4 cells per well ( 1 1 ) .  
In these experiments, uniformly labeled ‘‘C-gluco- 
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samine (254 mCi/mmole) was used at a concentration of 0.5 
pCi/ml, and 3’S04 at 50 pCi /d .  Measurement of incorpo- 
ration of ‘‘C-glucosamine and 35S04 into GAG was quanti- 
tated by a method reported recently (1 1). In brief, 100 pl of 
media was placed on 3 MM Whatman chromatography 
paper, and the GAG fixed to the paper by immersing it in a 
0.1% solution of cetylpyndinium chloride (CPC). Unincor- 
porated label was removed by sequential washes with 0.05M 
NaCl containing 0.1% CPC in the case of ‘‘C-labeled media, 
or with 0.3M NaCl for ”SO4 labeled media. 
Analytic methods. Fractionation of labeled GAG was 
carried out on 2.5 X 25 cm columns packed with Sephacryl 
S-300, Sepharose 4 3 ,  or Sepharose 2B in 0.5M acetate 
buffer, pH 6.9. Columns were calibrated with high molecular 
weight Dextran blue or proteoglycan aggregate to define the 
void volume (Vo) and with chondroitin sulfate deproteinized 
by alkaline borohydride reduction (12) to define the elution 
position of “free” GAG chains. In addition, the columns 
were calibrated for the elution position of albumin, cyto- 
chrome C, and ? 3 0 4 .  Radiolabeled media was lyophilized 
on removal from cultures, taken up in a small volume of 
column buffer, and dialyzed at 6°C against the same buffer 
before gel filtration studies. 
Identification of sulfated GAG species was accom- 
plished enzymatically using chondroitinases AC and ABC. 
Fifty microliters of radiolabeled GAG was incubated with 40 
pl of the appropriate buffer and 20 pl containing appropriate 
amounts of enzyme (for 2 hours) in Costar 96-well plates. 
After incubation, 100 pI was removed, spotted, and subject- 
ed to the CPC precipitation and washing procedure. With 
this procedure, enzymatic hydrolysis leads to loss of specific 
GAGs, and their identify may be inferred. 
Chemical methods included determination of protein 
by the method of Oyama and Eagle (13), and measurement of 
uronic acid by a modified carbazole procedure (14). 
CTAP-Ib was isolated from human spleen as reported 
earlier (2); CTAP-111 and CTAP-P2 were isolated from 
outdated human platelets as previously reported (43). 
RESULTS 
Evidence for synovial proteoglycan synthesis. 
Gel filtration of 35S04-containing media from human 
synovial cultures on a Sephacryl S-300 column showed 
most of the ?304-GAG eluting in the Vo, suggesting a 
molecular weight in excess of 0.75 x lo6 daltons 
(Figure 1). Duplicate cultures incubated with a @ 
xyloside (0-nitrophenyl-@D-xyloside) exhibited mark- 
edly increased synthesis (>6-fold) of sulfated GAGs; 
these had an elution volume corresponding to that of 
protein-free GAG chains. Detection of most of the 
35S04-GAG from control cultures in the Vo indicated a 
molecular volume consistent with proteoglycan mono- 
mer and implied the presence of “core protein” in this 
material. Gel filtration of ”S-PG on a Sepharose 2B 
column showed the labeled product to be in the 
retarded volume, indicating that it was proteoglycan 
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Figure 1. Cultures incubated with o-nitrophenyl-gD-xyloside (100 
d m l )  had enhanced incorporation of ’304 into glycosaminogly- 
cans. Gel filtration of labeled media on Sephacryl S-300 showed 
most counts from control cultures in the void volume, while @- 
xyloside treated cultures formed large amounts of “chain” size 
gl ycosaminoglycans. 
chain-sized GAG when cultures were supplemented 
with pxyloside as a false “core protein” (15) might 
suggest that factors controlling the rate of core protein 
formation (or linkage sites) may be more critical in 
limiting the overall rate of SO4-GAG synthesis than 
are considerations restricted to carbohydrate chain 
synthesis alone. 
Additional evidence for a protein component in 
the Vo fraction from the Sephacryl S-300 column was 
provided by studies in which alkaline borohydride 
hydrolysis removed protein from PG, thus reducing 
the molecular weight of the labeled material to that of 
GAG “chain.” Data plotted in Figure 2 show the 
elution position of 35S04-PG in the Vo, whereas a 
duplicate aliquot of labeled PG rendered protein-free 
by @elimination (alkaline borohydride hydrolysis) be- 
came smaller and eluted from the GAG “chain” 
volume of the calibrated column. 
Direct evidence for newly formed protein in the 
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Figure 2. Gel filtration of 35S-proteoglycan on Sephacryl S-300 
showed that removal of protein by alkaline borohydride hydrolysis 
altered the presumptive molecular weight from >0.75 X lo6 daltons 
to approximately 25 x 10' daltons. 
PG fraction came from experiments in which duplicate 
cultures were incubated with either I4C-amino acids or 
35S04, and the media subjected to gel filtration on a 
Sephacryl S-300 column. As shown in Figure 3, both 
the "S04-PG and ''C-macromolecular material were 
found in the Vo. The putative I4C-PG was insoluble in 
5% trichloroacetic acid (TCA). Incubation of the puta- 
tive I4C-PG with chondroitinase AC and ABC ren- 
dered little (0-3%) of the labeled material soluble in 
TCA, whereas the proteolytic enzyme pronase ren- 
dered most (77-86%) of the I4C-PG soluble in TCA. In 
addition, inclusion of 10 pg/ml cycloheximide in syno- 
vial cultures markedly (by 90%) reduced I4C-amino 
acid incorporation into TCA insoluble protein. We 
therefore concluded that the I4C-amino acids were 
primarily incorporated into protein, with virtually 
none detected in the GAG side chains of the proteogly- 
can monomer. 
The GAG chain composition of synovial PG 
from 2 normal and 2 rheumatoid cell strains is shown 
in Table 1 .  Cells cultivated under basal conditions (no 
additives) synthesized 35S04-GAG chains which were 
predominantly (48-64%) dermatan sulfate associated 
with a lesser amount (14-26%) of chondroitin 4/6 
sulfate. The enhanced formation of 3'S04-GAG in- 
duced by CTAP-I, CTAP-111, and CTAP-P2 included 
both dermatan sulfate (3453%) and chondroitin 416 
sulfate (17-34%). Data from the CTAP stimulated 
cultures suggested that synthesis of chondroitin 416 
sulfate might be disproportionately stimulated; this 
trend was even more strongly suggested in cultures in 
which S04-GAG synthesis was enhanced by including 
Pxylosides in the media. 
Another way to demonstrate that a portion of 
the 14C-macromolecular Vo material was actually 14C 
"core protein" would be to  digest such material with 
chondroitinase ABC and show that removal of unla- 
beled GAG chains from the monomer allowed the 14C 
core protein to elute from a calibrated gel filtration 
column in the 200-250,OOO dalton zone. To this end, 
cultures were incubated with either 35S04 (to label 
GAG chains) or I4C-amino acids (to label "core pro- 
tein''), and media was subjected to gel filtration on 
Sephacryl S-300. Material eluting in the Vo (3SS-PG 
and I4C-PG) was incubated with either buffer or chon- 
droitinase ABC (2.5 uni tshl)  for 18 hours at 37°C. As 
shown in Figure 4, when the incubated materials were 
subjected to repeat gel filtration, 35S04-PG incubated 
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Ngure 3. Gel filtration on a Sephacryl S-300 column of I4C-amino 
acid and "SO4 labeled macromolecules from synovial culture media 
showed that most incorporated isotope was in the void volume. 
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Table 1. Carbohydrate composition of synovial sulfated GAG and proteoglycans* 
% digested by: Synovial 
cell Chondroit- Chondroit- 
strain Additive inase AC inase ABC 
Normal 1 0 26 Y o  
R A l  0 23 83 
pxyloside 45 96 
Normal 2 0 14 62 
CTAP-I11 34 68 
CTAP-P2 21 70 
CTAP-I 26 63 
Cortisol 11 13 
R A 2  0 19 76 
CTAP-I11 20 73 
CTAP-P2 17 17 
CTAP-I 33 I8 
Cortisol I 1  16 
p x  yloside 38 93 
* GAG = glycosaminoglycan; RA = rheumatoid arthritis; CTAP = connective tissue activating 
peptides. 
with buffer still eluted in the Vo of a Sephacryl S-300 
column, while chondroitinase ABC treated material 
was markedly reduced in molecular weight and eluted 
near the end of the column volume. This clearly 
demonstrated that the enzymatic digestion condition 
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Figure 4. Gel filtration on a Sephacryl S-300 column showed that 
3'S-proteoglycan digested with chondroitinase ABC was rendered 
much smaller, eluting near the end of the column volume. 
had facilitated removal of the bulk of the GAG chain 
material from putative "core protein." 
Data from the parallel experiment in which 14C- 
PG was subjected to digestion with chondroitinase 
ABC are shown in Figure 5 .  In this experiment, the 
buffer treated 14C-PG was gel filtered on Sepharose 
4B, and a major radioactive peak was found in the Vo. 
Digestion with chondroitinase ABC markedly reduced 
the Vo peak, leading to a substantial increase in I4C 
protein in an internal volume peak with an elution 
position which would include core protein (16,171. The 
polydispersity of the ''C-proteins retarded in the 
Sepharose 4B column may relate to incomplete remov- 
al of GAG chains from the protein core as well as the 
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Figure 5. Gel filtration on a Sepharose 4B column showed that 
digestion of ''C-proteoglycan with chondroitinase ABC to remove 
unlabeled glycosaminoglycan chains reduced the size of the labeled 
component so that it eluted near the elution volume of bovine 
catalase. 
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peak in the 200,000 dalton region following gel filtra- 
tion of control I4C-PG may reflect the inclusion of 
lower molecular weight species from the original Se- 
phacryl S-300 Vo fraction used as starting material. 
Stimulation of synovial PG synthesis by autacoid 
mediators. The stimulatory effect of CTAP-I, CTAP- 
111, and CTAP-P2 on ’%04-PG formation is illustrated 
in Figure 6, which shows that all 3 mediators caused 
increased synovial cell synthesis of PG eluting in the 
Vo of a Sephacryl of S-300 column. In this experiment, 
cortisol modestly depressed PG formation. In a paral- 
lel experiment, replicate synovial cultures were incu- 
bated with 14C-amino acids in the presence of CTAP- 
111, buffer vehicle, or cycloheximide. As shown in 
Figure 7, CTAP-111 markedly increased 14C-protein 
formation which eluted in the Vo of a Sephacryl S-300 
column, while cycloheximide markedly depressed pro- 
tein synthesis in all size categories. A comparison of 
the effect of CTAP-111 labeling of synovial PG by 
35S04 or 14C-amino acids is shown in Table 2. As 
shown by the similarity in experimentalkontrol ratios, 
the magnitude of CTAP-I11 induced increment in 
35S04-GAG side chain was comparable with the incre- 
ment in 14c-core protein. 
DISCUSSION 
This report provides evidence that synovial 
lining cells form one or more sulfated proteoglycan 
monomers containing chondroitin 4/6 sulfate as the 
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Figure 6. Gel filtration on a Sephacryl S-300 column showed that 
connective tissue activating peptide mediators stimulated formation 
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Figure 7. tiel filtration on a Sephacryl S-300 column showed that 
connective tissue activating peptide 111 stimulated incorporation of 
I4C-amino acids into protein, particularly those eluting in the void 
volume. 
component. This contrasts with recent studies using 
skin fibroblasts, in which chondroitin 4/6 sulfate was 
the major component (18). Data supporting formation 
of PG include gel filtration data showing the ”S-PG is 
large (>0.75 x lo6 daltons), and data indicating the 
presence of “core protein.” The presence of core 
protein was supported by: 1) alkaline borohydride 
hydrolysis studies showing that removal of protein by 
&elimination reduced large PG molecules to chain- 
sized GAG, 2) I4C-arnino acid labeling of protein 
which elutes in the Vo of Sephacryl S-300 and Sephar- 
ose 4B columns, and 3) studies in which chondroitin- 
ase ABC digestion of PG labeled in the protein portion 
lead to gel filtration evidence that I4C-protein denuded 
of GAG eluted at an elution position compatible with 
the molecular weight of core protein. 
All 3 CTAPs tested stimulated formation of 35S- 
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Table 2. Comparison of ‘‘C-amino acid and ”SO, incorporation into synovial proteoglycan* 
Total radioactivity in Sephacryl 
S-300 Vo (cpm) 
Isotope 
Control CTAP-111 treated Experimentall 
cultures cultures control 






* cpm = counts per minute; CTAP = connective tissue activating peptides. 
PG; CTAP-I11 also stimulated formation of high mo- 
lecular weight I4C-protein (probably partly core pro- 
tein) to the same extent as it did 3’S-PG. Since adding 
Pxyloside as a “false core protein” led to marked 
enhancement of GAG chain formation, synthesis of 
the latter does not appear to be rate limiting. The data, 
in summary, suggest that autacoid mediator stimula- 
tion of PG formation may be primarily dependent on 
the accelerated synthesis of PG core protein. 
These studies, in agreement with others, show 
no difference between normal and rheumatoid cells 
with respect to sulfated GAG metabolism. The physio- 
logic sighificance of synovial cell synthesis of sulfated 
PG remains an enigma. 
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